People | April 04, 2023
Top management changes at IOL Chemicals and Pharmaceuticals
Vikas Vij has been appointed as Chief Executive Officer (CEO) of the company
Vikas Vij has been appointed as Chief Executive Officer (CEO) of the company
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
The company completed paracetamol capacity expansion by 1,800 MTPA and the company is now focusing on frugal manufacturing practices to reduce raw material cost and expand margins
Standalone Q3 FY23 revenue stood at Rs. 626.5 crore as against Rs. 594.8 crore, a growth of 5% YoY
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
The company is one of the most profitable companies manufacturing speciality chemicals in India
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
The pharma laboratory is fully equipped with all the machinery needed to support formulation development, resolve technical challenges, and provide customer demonstrations
The company registered with REACH Certificate for Ethyl Acetate with a tonnage band of more than 1000 TPA
The core of “LANXESS Biosecurity Solutions” is a portfolio of scientifically formulated, highly effective and versatile biocidal products
Subscribe To Our Newsletter & Stay Updated
